Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Condition: Clear Cell Metastatic Renal Cell Carcinoma
NCT02960906
A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: large_enrollment_target_signal | rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.